Literature DB >> 24483200

The enigma of metformin-associated lactic acidosis.

D N Juurlink1, D M Roberts.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24483200     DOI： 10.3109/15563650.2014.880174

Source DB:  PubMed          Journal:  Clin Toxicol (Phila)        ISSN： 1556-3650            Impact factor:   4.467


× No keyword cloud information.
  5 in total

1.  Retrospective analysis of lactic acidosis-related parameters upon and after metformin discontinuation in patients with diabetes and chronic kidney disease.

Authors:  Savas Sipahi; Yalcin Solak; Seyyid Bilal Acikgoz; Ahmed Bilal Genc; Mehmet Yildirim; Ulku Yilmaz; Ahmet Nalbant; Ali Tamer
Journal:  Int Urol Nephrol       Date:  2016-04-21       Impact factor: 2.370

2.  Complex decisions in the use of extracorporeal treatments in acute metformin overdose: which modality, when and how to measure the effect.

Authors:  Maurizio Stefani; Darren M Roberts
Journal:  Br J Clin Pharmacol       Date:  2018-10-03       Impact factor: 4.335

Review 3.  Metformin associated lactic acidosis (MALA): clinical profiling and management.

Authors:  Alessandra Moioli; Barbara Maresca; Andrea Manzione; Antonello Maria Napoletano; Daniela Coclite; Nicola Pirozzi; Giorgio Punzo; Paolo Menè
Journal:  J Nephrol       Date:  2016-01-22       Impact factor: 3.902

4.  Clinical Pharmacokinetics in Kidney Disease: Fundamental Principles.

Authors:  Tom N Lea-Henry; Jane E Carland; Sophie L Stocker; Jacob Sevastos; Darren M Roberts
Journal:  Clin J Am Soc Nephrol       Date:  2018-06-22       Impact factor: 8.237

Review 5.  Metformin as a cellular protector; a synoptic view of modern evidences.

Authors:  Nicolas Wiernsperger
Journal:  J Nephropharmacol       Date:  2015-01-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.